Press Release: Vibalogics : DPS Group Completes Work on New Virotherapy Manufacturing Facility ...

(PR-inside.com) BOSTON, MA / ACCESSWIRE / March 3, 2022 / DPS Group, a privately-owned, global engineering, procurement, construction management and validation (EPCMV) firm serving high-tech process industries, today announced it has completed work on a new, 118,000 SF late-phase clinical and commercial manufacturing facility at 1414 Massachusetts Avenue in Boxborough, Mass. for Vibalogics, a global contract development and manufacturing organization (CDMO). Specializing in the production of live-viruses and viral vectors, Vibalogics GMP facility will accelerate market supply of process & analytical development, manufacturing, testing, and aseptic fill-finish services to oncolytic virus, viral vector gene therapy and vaccine drug development companies during early-to-late ..